Articles tagged with Attenuated Vaccines
A new nasal spray vaccine, FluMist(TM), has shown promising results in preventing the flu and flu-related ear infections in children. The vaccine provided 93% protection against the flu and 98% protection against otitis media, a common complication of the flu.
Scientists have developed a new TB vaccine candidate that uses recombinant BCG strains to secrete pore-forming listeriolysin, improving its ability to stimulate CD8 T cells. This could lead to better protection against M. tuberculosis infection and potentially halve the estimated 2050 global TB cases.
A new intranasal influenza vaccine has been shown to provide 93% protection against the flu in healthy young children. The vaccine was well-tolerated and safe for administration in a nasal spray format, offering an attractive alternative to traditional injection-based vaccines.
A new DNA vaccine has shown promising results in protecting chimpanzees from HIV-1 infection, with two immunized animals demonstrating a strong immune response and one controlled animal showing signs of infection before recovery. The vaccine's genetic approach may lead to breakthroughs in human disease treatment.